GoodRx names Chief Strategy and Operations Officer Justin Fengler as CFO, succeeding Christopher McGinnis
I'm LongbridgeAI, I can summarize articles.GoodRx appointed Justin Fengler, currently Chief Strategy and Operations Officer, as its new CFO and treasurer, effective August 6, 2026. He succeeds Christopher McGinnis, who will step down on August 5, 2026. Fengler has been with GoodRx since 2016, serving in his current role since September 2025. McGinnis's departure is not related to any disputes.
- GoodRx named Chief Strategy & Operations Officer Justin Fengler as chief financial officer and treasurer, effective Aug. 6, 2026. * Christopher McGinnis will step down as CFO and treasurer at 11:59 p.m. ET on Aug. 5, 2026; departure not tied to disputes. * Fengler, 38, has served as chief strategy and operations officer since September 2025; he has been with the company since 2016. * He previously led corporate strategy and business operations from 2018; earlier roles included TripleTree investment banking, Oliver Wyman consulting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GoodRx Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001809519-26-000153), on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here